Studio LSD Ltd, which launched its Initial Public Offering (IPO) on August 18, 2025, made its debut on the National Stock Exchange (NSE) on August 25, 2025. The shares of Studio LSD Ltd made a weak debut, listing at a discount on the NSE SME platform.
The shares opened at ₹43.20 on the NSE, marking a discount of 20% over the IPO upper price band of ₹54. Ahead of its listing, the Grey Market Premium of Studio LSD Ltd stood at ₹0, indicating a flat listing.
(August 20, 2025, end of the day)
On Day 3, the Studio LSD IPO was subscribed 3.23 times. The public issue subscribed 4.58 times in the individual investors category, 1.00 times in QIB, and 1.25 times in the NII category.
Studio LSD IPO was a bookbuilding of ₹74.25 crores. The issue was a combination of fresh issue of 1.10 crore shares aggregating to ₹59.40 crores and offer for sale (OFS) of 0.28 crore shares aggregating to ₹14.85 crores.
The issue price band was set at ₹51 to ₹54 per share. The minimum lot size for an application was 4,000 (2 lots), and the minimum investment amount required for a retail investor was ₹2,04,000.
Corpwis Advisors Pvt. Ltd. was the book running lead manager, and Purva Sharegistry (India) Pvt. Ltd. was the registrar of the issue. The market maker of the company is Rikhav Securities Ltd.
Check out newly Listed IPOs on BSE and NSE.
Studio LSD Limited, incorporated in February 2017 and headquartered in Mumbai, is a dynamic multimedia production house that specialises in creating original, genre-diverse content for television and OTT platforms.
The company offers content production services such as concept development, script writing, line production, post-production, and distribution & marketing support. It serves major broadcasters and streaming platforms across India.
In FY25, Studio LSD posted a revenue of ₹105.01 crore, compared to ₹102.49 crore in FY24 and Profit After Tax (PAT) increased to ₹11.67 crore. As of FY25, the total assets of the company stood at ₹46.67 crore.
Explore other Upcoming IPOs on BSE and NSE.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.